全文获取类型
收费全文 | 119218篇 |
免费 | 12542篇 |
国内免费 | 7300篇 |
专业分类
耳鼻咽喉 | 1090篇 |
儿科学 | 1867篇 |
妇产科学 | 824篇 |
基础医学 | 9302篇 |
口腔科学 | 1975篇 |
临床医学 | 14754篇 |
内科学 | 12706篇 |
皮肤病学 | 1352篇 |
神经病学 | 3881篇 |
特种医学 | 4536篇 |
外国民族医学 | 29篇 |
外科学 | 10818篇 |
综合类 | 28715篇 |
现状与发展 | 33篇 |
一般理论 | 11篇 |
预防医学 | 12531篇 |
眼科学 | 2334篇 |
药学 | 14063篇 |
205篇 | |
中国医学 | 10630篇 |
肿瘤学 | 7404篇 |
出版年
2024年 | 607篇 |
2023年 | 1734篇 |
2022年 | 4226篇 |
2021年 | 5447篇 |
2020年 | 4570篇 |
2019年 | 3125篇 |
2018年 | 3171篇 |
2017年 | 3865篇 |
2016年 | 3288篇 |
2015年 | 5168篇 |
2014年 | 6783篇 |
2013年 | 7689篇 |
2012年 | 10750篇 |
2011年 | 11276篇 |
2010年 | 9489篇 |
2009年 | 8029篇 |
2008年 | 8641篇 |
2007年 | 8406篇 |
2006年 | 7576篇 |
2005年 | 6129篇 |
2004年 | 4336篇 |
2003年 | 3872篇 |
2002年 | 3186篇 |
2001年 | 2504篇 |
2000年 | 1765篇 |
1999年 | 951篇 |
1998年 | 417篇 |
1997年 | 418篇 |
1996年 | 299篇 |
1995年 | 226篇 |
1994年 | 200篇 |
1993年 | 152篇 |
1992年 | 110篇 |
1991年 | 102篇 |
1990年 | 93篇 |
1989年 | 95篇 |
1988年 | 53篇 |
1987年 | 53篇 |
1986年 | 50篇 |
1985年 | 41篇 |
1984年 | 27篇 |
1983年 | 28篇 |
1982年 | 15篇 |
1981年 | 11篇 |
1980年 | 7篇 |
1979年 | 18篇 |
1978年 | 10篇 |
1977年 | 10篇 |
1975年 | 6篇 |
1956年 | 5篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
目的对不同季铵化程度(DQ)的N-三甲基壳聚糖(TMC)促进阿昔洛韦(ACV)滴眼液眼部滞留性进行考察。方法将浓度为0.5%,DQ分别为20%、40%及60%的TMC(TMC20,TMC40,TMC60)加入ACV滴眼液中;以同浓度壳聚糖(CS)ACV滴眼液为阳性对照,以普通ACV滴眼液为阴性对照,选用家兔为实验动物,采用悬挂泡技术和束缚泡技术进行离体眼球表面接触角及解吸附动力学进行研究,同时在各种ACV滴眼液中分别加入0.05%的荧光素钠为示踪剂,在体研究各种ACV滴眼液在家兔眼部的滞留性。结果与普通ACV滴眼液相比,含CS及TMC的滴眼液在角膜表面的接触角明显降低,解吸时间及在体滞留时间明显延长(P<0.05);与同浓度的CS ACV阳性对照相比,TMC20促进滞留作用较弱,而TMC40作用差异无显著性(P>0.05),而TMC60的作用明显较强(P<0.05)结论 TMC可显著增加ACV的眼部滞留性,且与其DQ呈正相关。 相似文献
2.
Sophocarpine attenuates toll‐like receptor 4 in steatotic hepatocytes to suppress pro‐inflammatory cytokines synthesis 下载免费PDF全文
3.
4.
5.
随着整体理论、吊床理论及肛提肌维持盆底器官的重要性等多种观点的提出,盆底器官脱垂(POP)发病机制复杂临床表现多样化,因此获得POP的完整信息,应结合临床检查及辅助检查手段,在辅助检查手段中应用最广泛、最有优势的影像学技术。多种影像学技术应用于盆底,包括静态及动态盆底影像学技术,帮助临床医师全面了解POP的发病机制、诊断并建立盆底治疗方案及完善的术后随访体系。 相似文献
6.
Multidisciplinary predialysis education and team care (MDC) may slow the decline in renal function in patients with chronic kidney disease (CKD). However, associations between unexpected return during MDC and progression of renal dysfunction have not been characterized in patients with CKD. Our study aimed to determine the association between exacerbation of renal dysfunction and the frequency of unexpected return during follow-up.A total of 437 patients with CKD receiving multidisciplinary care between January 2009 and June 2013 at the Shin-Kong Wu Ho-Su Memorial Hospital were included in this retrospective observational cohort study, and multiple imputations were performed for missing data. The predictor was the frequency of unexpected return for follow-up during the first year after entering MDC. Main outcome was monthly declines in estimated glomerular filtration rates (eGFR). Moreover, the demographic data, comorbidities, history of medication, and routine laboratory data for patients with CKD were collected.Among all patients, 59.7% were male, the mean age at initiation of MDC was 69.4 ± 13.2 years, and the duration of follow-up was 21.4 ± 3.3 months. The subjects were divided into 2 groups according to frequencies of follow-up (≤4 and > 4 visits) during the 1st year of MDC. The patients with CKD were regularly followed up every 3 months as a part of MDC in our hospital, and patients who returned for more than 4 follow-up visits were included in the unexpected return group. In crude regression analyses, unexpected return was significantly associated with higher monthly declines of eGFR (β = 0.092, 95% confidence interval, 0.014–0.170). This association remained after adjustments for multiple variables, and subgroup analyses of unexpected return showed that male gender, older age, CKD stage 1 to 3, hypertension, history of coronary artery disease, and use of renin–angiotensin system blockade were significantly associated with declines in renal function.In conclusion, unexpected return for follow-up during the 1st year of MDC was significantly associated with the deterioration of renal function. 相似文献
7.
8.
The associations between saturated fatty acid (SFA) consumption and risk of breast cancer (BC) remains inconclusive. Therefore, we conducted this meta-analysis to determine the quantitative relations between dietary SFA intake and incidence of BC.Literatures published up to April 2015 were systematically screened through Pubmed and Web of Science. Relevant publication quality was evaluated by conducting the Newcastle-Ottawa scale. We used fixed effects models or random effect models to calculate the summary relative risks (RRs) and odds ratios (ORs), and conducted sensitivity analyses and evaluated the publication bias.We identified a total of 52 studies (24 cohort studies and 28 case–control studies), with over 50,000 females diagnosed with BC. The associations between dietary SFA intake and risk of BC were 1.18 for case–control studies (high vs low intake, 95% confidence interval [CI] = 1.03–1.34) and 1.04 for cohort studies (95% CI = 0.97–1.11). When restricted analyses to population-based studies, positive associations were observed for both cohort (RR [95% CI] = 1.11 [1.01–1.21]) and case–control studies (OR [95% CI] = 1.26 [1.03–1.53]). Additionally, for case–control studies, significant positive associations between higher SFA intake and BC risk were observed for Asian (OR [95% CI] = 1.17 [1.02–1.34]) and Caucasian (OR [95% CI] = 1.19 [1.00–1.41]), as well as for postmenopausal women (OR = 1.33, 95% CI: 1.02–1.73). In contrast, higher dietary SFA intake was not associated with risk of BC among premenopausal women, in cohort studies or hospital-based studies.A positive association between higher dietary SFA intake and postmenopausal BC risk was observed in case–control but not in cohort studies. More studies are warranted to confirm these findings. 相似文献
9.
10.